Nieminen M S, Mattila K J, Aalto-Setälä K, Kuusi T, Kontula K, Kauppinen-Mäkelin R, Ehnholm C, Jauhiainen M, Valle M, Taskinen M R
Department of Medicine, University of Helsinki, Finland.
Arterioscler Thromb. 1992 Jan;12(1):58-69. doi: 10.1161/01.atv.12.1.58.
To examine the concentration of serum lipoproteins and the association of their genetic variation with the occurrence of coronary artery disease (CAD), composite serum lipoprotein profiles including lipoprotein(a) (Lp[a]), apolipoprotein (apo) E phenotypes, and apo B Xba I genotypes were determined in patients with angiographically verified CAD (CAD+ group, n = 111) and in subjects with no angiographic evidence of CAD (CAD- group, n = 46). In addition, we determined the concentrations of serum lipids, lipoproteins, and apolipoproteins in 96 healthy controls. Both CAD- and CAD+ groups had lower concentrations of apos A-I and A-II but higher concentrations of serum total and very low density lipoprotein triglyceride and very low density lipoprotein cholesterol than did healthy controls. The mean concentrations of serum total and low density lipoprotein cholesterol and the median values of Lp(a) were similar in the CAD+ and CAD- groups, both having higher concentrations of low density lipoprotein cholesterol and apo B than the healthy controls. Irrespective of gender, patients with CAD had significantly lower serum high density lipoprotein cholesterol than did those without CAD (1.48 +/- 0.40 versus 1.16 +/- 0.29 mmol/l, p less than 0.001). In women, the mean serum total and very low density lipoprotein triglyceride concentration was also higher in the CAD+ than in the CAD- group. The frequency of the apo E4 allele (epsilon 4) was significantly higher in the CAD+ group (0.293) than in the CAD- group (0.174; p less than 0.001). The frequencies of the two apo B alleles, X1 (Xba I restriction site absent) and X2 (Xba I restriction site present), were similar in the two groups. Stepwise discriminant analysis revealed that in men, serum high density lipoprotein cholesterol had the highest power to discriminate for CAD. In addition, the concentration of plasma apo B levels and the occurrence of apo E phenotypes were independently associated with CAD in men. In women, the only independent factor associated with CAD after adjustment for beta-blocker and diuretics usage was the concentration of serum triglycerides.
为了检测血清脂蛋白浓度及其基因变异与冠状动脉疾病(CAD)发生之间的关联,我们测定了经血管造影证实患有CAD的患者(CAD+组,n = 111)以及无CAD血管造影证据的受试者(CAD-组,n = 46)的复合血清脂蛋白谱,包括脂蛋白(a)(Lp[a])、载脂蛋白(apo)E表型和apo B Xba I基因型。此外,我们还测定了96名健康对照者的血清脂质、脂蛋白和载脂蛋白浓度。与健康对照者相比,CAD-组和CAD+组的apo A-I和A-II浓度较低,但血清总甘油三酯和极低密度脂蛋白甘油三酯以及极低密度脂蛋白胆固醇浓度较高。CAD+组和CAD-组的血清总胆固醇和低密度脂蛋白胆固醇平均浓度以及Lp(a)中位数相似,两者的低密度脂蛋白胆固醇和apo B浓度均高于健康对照者。无论性别如何,CAD患者的血清高密度脂蛋白胆固醇均显著低于无CAD者(1.48±0.40对1.16±0.29 mmol/l,p<0.001)。在女性中,CAD+组的血清总甘油三酯和极低密度脂蛋白甘油三酯平均浓度也高于CAD-组。CAD+组中apo E4等位基因(ε4)的频率(0.293)显著高于CAD-组(0.174;p<0.001)。两组中两个apo B等位基因X1(无Xba I限制性位点)和X2(有Xba I限制性位点)的频率相似。逐步判别分析显示,在男性中,血清高密度脂蛋白胆固醇对CAD的判别能力最强。此外,血浆apo B水平浓度和apo E表型的出现与男性CAD独立相关。在女性中,在调整β受体阻滞剂和利尿剂使用情况后,与CAD相关的唯一独立因素是血清甘油三酯浓度。